WASHINGTON D.C. — Today, Congressman Larry Bucshon, M.D. (IN-08) and Congresswoman Diana DeGette (CO-01) released the following statement after the Food and Drug Administration (FDA) finalized a rule regulating lab-developed tests (LDTs), a subset of in-vitro clinical tests (IVCTs).
“Rational oversight of in-vitro diagnostics, including laboratory-developed tests, is vital for innovation… Read more »
WASHINGTON – Today, U.S. Representative Larry Bucshon, M.D. (R-IN-08) joined a bipartisan group of Members of Congress to introduce the Supplemental Oxygen Access Reform (SOAR) Act. The legislation makes critical reforms to improve access to supplemental oxygen for Medicare beneficiaries. Dr. Bucshon was joined in introduction by Reps. David Valadao (CA-22), Julia… Read more »
WASHINGTON – Today, the U.S. House Energy and Commerce Subcommittee on Health held a hearing focused on evaluating approaches to diagnostic test regulation. U.S. Representative Larry Bucshon, M.D. (R-IN-08), Vice Chair of the Health Subcommittee, has been a leading voice calling for the creation of a new framework to verify the accuracy of various medical tests… Read more »
WASHINGTON – Today, U.S. Representative Larry Bucshon, M.D. (R-IN-08) voted to pass the Dr. Michael C. Burgess Preventive Health Savings Act (H.R. 766) to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Dr. Bucshon spoke in favor of the Dr. Michael C. Burgess Preventive Health… Read more »
WASHINGTON – U.S. Representatives Larry Bucshon, M.D. (R-IN-08), and Ami Bera, M.D. (D-CA-06) on March 6, 2024, penned a letter to U.S. Department of Health and Human Services Secretary Becerra regarding the recent cybersecurity attack on Change Healthcare. The substance of their request—that the agency work to protect all types of providers… Read more »
WASHINGTON – Today, U.S. Representative Larry Bucshon, M.D. (R-IN-08) voted to pass the Consolidated Appropriations Act, 2024. This appropriations package helps rein in out-of-control Washington spending and put an end to budgetary waste, without compromising on the commitment to support physicians, veterans, or shortchanging investments in national security. Dr.… Read more »
WASHINGTON – U.S. Representative Larry Bucshon, M.D. (R-IN-08) was presented with the American Medical Association (AMA) Award for Outstanding Government Service – United States Representative, for his years of work on issues critical to patients and physicians. This award recognizes Dr. Bucshon’s relentless efforts to prevent devastating Medicare physician payment cuts and his… Read more »
WASHINGTON – Today, Representatives Larry Bucshon, MD (IN-08) and Suzan DelBene (WA-01), Co-Chairs of the Congressional Kidney Caucus, released the following statement on National Donor Day.
“Today we honor all those who have selflessly donated organs and tissue to save the lives of their families, friends, and fellow Americans. As Co-Chairs of the… Read more »
WASHINGTON – Today, U.S. Representatives Larry Bucshon, M.D. (R-IN-08), Mike Kelly (R-PA-16), Suzan DelBene (D-WA-01), Ami Bera, M.D. (D-CA-06), and U.S. Senators Roger Marshal, M.D. (R-KS), Sherrod Brown (D-OH), John Thune (R-SD), and Kyrsten Sinema (I-AZ) issued the following statement on CMS’ long-awaited prior authorization regulations:
“Today’s action by CMS is a… Read more »
WASHINGTON – Last week, U.S. Representatives Larry Bucshon, M.D. (R-IN-08) and Doris Matsui (D-CA-07) introduced the Mapping America’s Pharmaceutical Supply (MAPS) Act, a bill to help the federal government prepare for and mitigate future drug shortages by identifying pharmaceutical supply chain vulnerabilities. The MAPS Act would require the Department of Health… Read more »
